Nimia Reyes
Overview
Explore the profile of Nimia Reyes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Lam B, Zerbey S, Rosovsky R, Lake L, Dodge L, et al.
Blood Vessel Thromb Hemost
. 2025 Jan;
1(4).
PMID: 39868029
No abstract available.
2.
Lam B, Dodge L, Zerbey S, Robertson W, Rosovsky R, Lake L, et al.
Sci Rep
. 2024 May;
14(1):12010.
PMID: 38796561
Venous thromboembolism (VTE) is the leading cause of preventable death in hospitalized patients. Artificial intelligence (AI) and machine learning (ML) can support guidelines recommending an individualized approach to risk assessment...
3.
Lam B, Chrysafi P, Chiasakul T, Khosla H, Karagkouni D, McNichol M, et al.
Blood Adv
. 2024 Mar;
8(12):2991-3000.
PMID: 38522096
Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality. Monitoring VTE cases is limited by the challenges of manual medical record review and diagnosis code interpretation. Natural language...
4.
Lam B, Zerbey S, Pinson A, Robertson W, Rosovsky R, Lake L, et al.
Res Pract Thromb Haemost
. 2024 Jan;
7(8):102272.
PMID: 38169996
No abstract available.
5.
Chiasakul T, Lam B, McNichol M, Robertson W, Rosovsky R, Lake L, et al.
Eur J Haematol
. 2023 Oct;
111(6):951-962.
PMID: 37794526
Background: Accurate diagnostic and prognostic predictions of venous thromboembolism (VTE) are crucial for VTE management. Artificial intelligence (AI) enables autonomous identification of the most predictive patterns from large complex data....
6.
Lam B, Dodge L, Datta S, Rosovsky R, Robertson W, Lake L, et al.
Res Pract Thromb Haemost
. 2023 Sep;
7(6):102168.
PMID: 37767063
Background: Venous thromboembolism (VTE) is a leading cause of preventable mortality among hospitalized patients, but appropriate risk assessment and thromboprophylaxis remain underutilized or misapplied. Objectives: We conducted an electronic survey...
7.
Wendelboe A, Saber I, Dvorak J, Adamski A, Feland N, Reyes N, et al.
JMIR Bioinform Biotechnol
. 2023 May;
3(1):e36877.
PMID: 37206160
Background: Venous thromboembolism (VTE) is a preventable, common vascular disease that has been estimated to affect up to 900,000 people per year. It has been associated with risk factors such...
8.
Saber I, Adamski A, Kuchibhatla M, Abe K, Beckman M, Reyes N, et al.
Res Pract Thromb Haemost
. 2022 Jul;
6(5):e12769.
PMID: 35873215
Background: Venous thromboembolism (VTE) affects approximately 1-2 individuals per 1000 annually and is associated with an increased risk for pulmonary hypertension, postthrombotic syndrome, and recurrent VTE. Objective: To determine risk...
9.
Ortel T, Arnold K, Beckman M, Brown A, Reyes N, Saber I, et al.
Appl Clin Inform
. 2019 Aug;
10(3):552-562.
PMID: 31365941
Background: Systematic surveillance for venous thromboembolism (VTE) in the United States has been recommended by several organizations. Despite adoption of electronic medical records (EMRs) by most health care providers and...
10.
Van Dyne E, Neaterour P, Rivera A, Bello-Pagan M, Adams L, Munoz-Jordan J, et al.
Open Forum Infect Dis
. 2019 Jan;
6(1):ofy325.
PMID: 30631791
Background: Zika virus (ZIKV) infection has been associated with severe thrombocytopenia. We describe the incidence, clinical manifestations, and outcomes of patients with ZIKV infection and thrombocytopenia. Methods: We reviewed medical...